02.07.2013 Betagenex's founders will attend the French Speaking Society of Diabetes annual congress, March 26-29, 2013, France
During this annual congress, Pr Poitout will lead a symposium on the beta-cell as a therapeutic target for type II diabetes.
10.04.2012 Dr Alexandre Charbonneau joins Bêtagenex’s team as senior scientist
Dr Alexandre Charbonneau is an expert in physiology with a focus on energy metabolism, obesity, inflammation and diabetes.
06.14.2012 Betagenex expands scientific team
Betagenex strengthen its scientific team with the arrival of three new persons to face an important increase of the activity. Many companies already trusts Betagenex’s expertise on diabetes and innovative approaches.
03.29.2012 The Cardiometabolic hub is launched!
The cardiometabolic hub is a consortium of highly specialized contract research organizations that pool their scientific expertises, preclinical and clinical skills and technical resources to provide outstanding research services and consulting for pharmaceutical, biotechnology and nutraceutical companies worldwide.
02.07.2012 A new study from Pr Poitout’s team reveals how glucose regulates GPR40 gene expression in pancreatic B-cells.
GPR40 is considered a potential therapeutic target to enhance insulin secretion in type 2 diabetes; however, its mode of regulation is mainly unknown. A better understanding of the regulation of this receptor is important to meet diabetes research and pharmaceutical industry needs.
11.23.2011 Pr Vincent Poitout is appointed Scientific Director of the CRCHUM
We are pleased to announce the nomination of Pr Vincent Poitout as Scientific Director of the Research Centre of the University of Montreal Hospital.
11.11.2011 Pr Vincent Poitout is invited to present “The ß-cell response to metabolic stress” at the World Diabetes Congress 4-8 December 2011, in Dubaï.
The oral presentation will take place within the “Stressing out the B-Cell” symposium from Clinical and Basic Science Stream, December 5th at 9:30 am in the Dubai International Convention and Exhibition Centre.
10.25.2011 Pr Marc Prentki awarded by the European Association for the Study of Diabetes (EASD)
Pr Marc Prentki has been awarded the 2011 Albert Renold Prize by the European Association for the Study of Diabetes (EASD) for "outstanding achievements in research on the islets of Langerhans".
05.19.2011 Dr Vincent Poitout will attend the 2011 American Diabetes Association annual meeting, June 24th-28th 2011 in San Diego, California, USA.
Vincent Poitout, DVM, PhD (Betagenex founder, Chair of the Board of Directors) and Thierry Sulpice, PhD (Betagenex founder, CEO and CSO and Physiogenex, CSO and Managing Director) will attend the 2011 ADA meeting.
02.08.2013 New scientific publications
Two scientific publications from Pr Poitout and Pr Prentki's teams have been published regarding insulin secretion.